Ostatní
Návod 
Jazz Pharmaceuticals plc
JAZZ
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
8.1B
Obrat
4B
Zisk
0B
Aktiva
11B
Dluh
5B
ROE
-9%
ROA
-3%
PE
-31
PS
3
Cena 1R
95-183
⌀ Cena
129.70
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
24-02-2026
Poslední dividenda
Profil
Biofarmaceutická společnost Jazz Pharmaceuticals plc identifikuje, vyvíjí a komercializuje farmaceutické produkty pro různé nenaplněné lékařské potřeby ve Spojených státech, Evropě a na mezinárodní úrovni. Společnost má portfolio produktů a kandidátů na produkty se zaměřením na oblasti neurovědy, včetně spánkové medicíny a pohybových poruch; a v onkologii, včetně hematologických a solidních nádorů. Mezi olověné přípravky uváděné na trh patří Xyrem, perorální roztok pro léčbu kataplexie a nadměrné denní ospalosti (EDS) u pacientů s narkolepsií ve věku sedmi let a starších; Sunosi pro léčbu EDS u pacientů s narkolepsií a obstrukční spánkovou apnoí; Erwinaze pro léčbu akutní lymfoblastické leukémie; Defitelio pro léčbu dospělých a pediatrických pacientů s jaterní veno-okluzivní chorobou; Vyxeos liposom pro injekci, přípravek pro léčbu dospělých s nově diagnostikovanou akutní myeloidní leukémií; a Zeeloidní leukémií; pzelca pro léčbu dospělých pacientů s metastazujícím malobuněčným karcinomem plic. Společnost rovněž nabízí Xywav, kandidáta na oxybutyrát, k léčbě EDS a kataplexie s narkolepsií a idiopatickou hypersomnií; JZP-324, nízkosodíkovou formu oxybutyrátu s potenciálem poskytnout klinicky smysluplnou volbu pro pacienty s narkolepsií; JZP385, modulátor vápníkového kanálu typu T, k léčbě esenciálního tremoru; JZP458, rekombinantní erwinia asparagináza, k použití jako součást kombinovaného chemoterapeutického režimu při léčbě pediatrických a dospělých pacientů; a JZP150 k léčbě posttraumatické léčby atická stresová porucha. Společnost má licenční smlouvy a smlouvy o spolupráci se společnostmi ImmunoGen, Inc., Codiak BioSciences, Inc., Pfenex, Inc., XL-protein GmbH a Redx Pharma plc. Společnost Jazz Pharmaceuticals plc byla založena v roce 2003 a sídlí v irském Dublinu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
2800
Založení
2007-06-01
Podobné společnosti
$ 69.78
- $ 0.06
$ 95.23
- $ 0.01
$ 487.29
- $ 1.97
$ 61.81
+ $ 1.65
$ 68.88
+ $ 0.64
$ 96.93
- $ 3.37
$ 91.82
- $ 1.54
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 4,267.6 | 4,267.6 | 4,069.0 | 3,834.2 | 3,659.4 | 3,094.2 | 2,363.6 | 2,161.8 | 1,890.9 | 1,618.7 | 1,488.0 | 1,324.8 | 1,172.9 | 872.4 | 586.0 | 272.3 | 173.8 | |
| Cost of Revenues | 503.3 | 503.3 | 445.7 | 435.6 | 540.5 | 440.8 | 148.9 | 127.9 | 121.5 | 110.2 | 105.4 | 102.5 | 117.4 | 102.1 | 78.4 | 13.9 | 13.6 | |
| Gross Profit | 3,764.3 | 3,764.3 | 3,623.2 | 3,398.6 | 3,118.9 | 2,653.5 | 2,214.7 | 2,033.8 | 1,769.4 | 1,508.5 | 1,382.6 | 1,222.3 | 1,055.5 | 770.3 | 507.6 | 258.3 | 160.2 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,197.9 | 1,126.1 | 1,045.7 | 897.8 | 1,088.2 | 1,055.0 | 1,023.8 | 902.0 | 1,011.9 | 972.1 | |
| Cost of Revenues | 24.6 | 257.8 | 116.3 | 104.6 | 128.7 | 111.6 | 109.9 | 95.5 | 258.8 | 102.2 | |
| Gross Profit | 1,173.3 | 868.3 | 929.4 | 793.2 | 959.5 | 943.4 | 913.9 | 806.5 | 753.1 | 870.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 849.7 | 590.5 | 505.7 | 335.4 | 299.7 | 226.6 | 198.4 | 162.3 | 135.3 | 85.2 | 46.6 | 20.5 | 14.1 | 25.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 1,343.1 | 1,417.0 | 1,451.7 | 854.2 | 736.9 | 683.5 | 544.2 | 502.9 | 449.1 | 406.1 | 304.3 | 223.9 | 108.9 | 69.0 | |
| Depreciation & Amortization | 542.0 | 542.0 | 660.1 | 638.7 | 599.2 | 525.8 | 259.6 | 464.8 | 201.5 | 152.1 | 102.0 | 98.2 | 126.6 | 82.1 | 74.2 | 7.8 | 7.8 | |
| Total Operating Expenses | 3,539.9 | 3,539.9 | 2,906.6 | 2,820.0 | 2,606.6 | 2,483.2 | 1,449.2 | 1,391.5 | 1,111.6 | 894.7 | 767.2 | 682.5 | 617.9 | 430.0 | 309.7 | 130.5 | 102.4 | |
| Operating Income | 224.4 | 224.4 | 716.6 | 578.6 | 512.3 | 170.3 | 765.5 | 532.4 | 614.8 | 528.8 | 591.7 | 508.2 | 195.6 | 340.3 | 197.8 | 127.8 | 57.8 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 216.6 | 234.4 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 334.3 | 308.3 | ||
| Depreciation & Amortization | 24.9 | 178.2 | 174.0 | 164.9 | 168.4 | 165.2 | 163.0 | 163.4 | 159.2 | 162.6 | ||
| Total Operating Expenses | 264.1 | 810.8 | 1,615.8 | 849.1 | 768.7 | 683.1 | 714.5 | 740.3 | 550.9 | 697.6 | ||
| Operating Income | 909.2 | 57.5 | -686.4 | -55.9 | 190.8 | 260.2 | 199.4 | 66.2 | 202.2 | 172.4 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Interest Expense | 195.1 | 195.1 | 238.1 | 289.4 | 288.2 | 278.8 | 99.7 | 72.3 | 77.1 | 77.8 | 61.9 | 56.9 | 52.7 | 26.9 | 16.9 | 1.7 | 12.7 | |
| Other Expense | -853.0 | -853.0 | -247.9 | -280.7 | -885.1 | -283.1 | -490.4 | -78.1 | -51.2 | -95.0 | -21.0 | -46.9 | -233.3 | -5.4 | -3.6 | -1.2 | -12.3 | |
| IBT | -628.6 | -628.6 | 468.7 | 297.9 | -372.8 | -112.8 | 275.1 | 454.3 | 529.5 | 441.1 | 532.4 | 435.9 | 151.6 | 308.0 | 177.4 | 125.0 | 32.8 | |
| Income Tax Expense | -272.4 | -272.4 | -91.4 | -119.9 | -158.6 | 216.1 | 33.5 | -73.2 | 80.2 | -47.7 | 135.2 | 106.4 | 94.2 | 91.6 | -83.8 | 2.8 | 25.0 | |
| Net Income | -356.1 | -356.1 | 560.1 | 414.8 | -214.1 | -329.0 | 238.6 | 523.4 | 447.1 | 487.8 | 396.8 | 329.5 | 58.4 | 216.3 | 288.6 | 125.0 | 32.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.7 | 19.2 | ||
| Interest Expense | 45.4 | 48.6 | 47.4 | 53.7 | 51.3 | 58.7 | 62.0 | 66.1 | 89.7 | 71.5 | ||
| Other Expense | -700.9 | -48.5 | -49.2 | -54.5 | -57.6 | -59.7 | -61.5 | -69.2 | -61.0 | -72.9 | ||
| IBT | 208.3 | 9.0 | -735.6 | -110.4 | 133.2 | 200.5 | 137.9 | -2.9 | 61.5 | 99.5 | ||
| Income Tax Expense | 4.9 | -242.4 | -17.1 | -17.8 | -57.9 | -14.5 | -30.7 | 11.7 | -33.1 | -47.2 | ||
| Net Income | 203.5 | 251.4 | -718.5 | -92.5 | 191.1 | 215.1 | 168.6 | -14.6 | 94.2 | 146.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $6.95 | $-3.42 | $-5.51 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | $3.71 | $5.09 | $3.01 | $0.90 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $6.10 | $-3.42 | $-5.51 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | $3.51 | $4.79 | $2.67 | $0.83 | |
| Shares Outstanding | 61.0 | 61.0 | 61.8 | 63.3 | 62.5 | 59.7 | 55.7 | 56.7 | 60.0 | 60.0 | 60.5 | 61.2 | 59.7 | 58.3 | 56.6 | 41.5 | 36.3 | |
| Diluted Shares Outstanding | 61.0 | 61.0 | 66.0 | 72.1 | 62.5 | 59.7 | 56.5 | 57.6 | 61.2 | 61.3 | 61.9 | 63.0 | 62.6 | 61.6 | 60.2 | 46.8 | 39.4 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.50 | $2.33 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.35 | $2.06 | ||
| Shares Outstanding | 61.0 | 60.7 | 61.2 | 61.0 | 60.5 | 61.4 | 62.9 | 62.5 | 62.6 | 63.1 | ||
| Diluted Shares Outstanding | 61.0 | 61.6 | 61.2 | 61.0 | 61.5 | 63.2 | 69.6 | 62.5 | 69.7 | 71.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,295.8 | 2,412.9 | 1,506.3 | 881.5 | 591.4 | 1,057.8 | 637.3 | 309.6 | 386.0 | 366.0 | 988.8 | 684.0 | 636.5 | 387.2 | 82.1 | 44.8 | |
| Short Term Investments | 685.0 | 580.0 | 120.0 | 0.0 | 0.0 | 1,075.0 | 440.0 | 515.0 | 215.0 | 60.0 | 0.0 | 0.0 | 0.0 | 0.0 | 75.8 | 0.0 | |
| Total Cash & ST Investments | 1,980.8 | 2,992.9 | 1,626.3 | 881.5 | 591.4 | 2,132.8 | 1,077.3 | 824.6 | 601.0 | 426.0 | 988.8 | 684.0 | 636.5 | 387.2 | 157.9 | 44.8 | |
| Accounts Receivable | 698.0 | 716.8 | 705.8 | 651.5 | 563.4 | 396.5 | 356.0 | 263.8 | 224.1 | 234.2 | 209.7 | 186.4 | 124.8 | 75.5 | 34.4 | 22.1 | |
| Inventory | 542.6 | 480.4 | 597.0 | 714.1 | 1,072.7 | 95.4 | 78.6 | 53.0 | 43.2 | 34.1 | 19.5 | 30.0 | 28.7 | 26.5 | 3.9 | 5.0 | |
| Other Current Assets | 274.5 | 439.0 | 506.3 | 267.2 | 252.4 | 152.5 | 78.9 | 67.6 | 76.7 | 29.3 | 19.0 | 21.3 | 33.8 | 19.1 | 1.3 | 0.3 | |
| Total Current Assets | 3,495.9 | 4,629.0 | 3,435.4 | 2,606.1 | 2,611.3 | 2,839.6 | 1,630.3 | 1,234.0 | 968.3 | 748.1 | 1,257.7 | 1,015.8 | 864.6 | 551.6 | 199.1 | 74.5 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,236.1 | 1,189.9 | 1,861.9 | 2,412.9 | 2,218.1 | 1,355.8 | 1,443.4 | 1,206.3 | 1,335.7 | 1,282.3 | |
| Short Term Investments | 810.0 | 480.0 | 710.0 | 580.0 | 400.0 | 625.0 | 375.0 | 420.0 | 250.0 | 80.0 | |
| Total Cash & ST Investments | 2,046.1 | 1,669.9 | 2,571.9 | 2,992.9 | 2,618.1 | 1,980.8 | 1,818.4 | 1,626.3 | 1,585.7 | 1,362.3 | |
| Accounts Receivable | 764.4 | 714.0 | 653.0 | 716.8 | 723.6 | 698.0 | 707.1 | 705.8 | 627.8 | 610.4 | |
| Inventory | 483.1 | 505.0 | 492.8 | 480.4 | 539.3 | 542.6 | 577.3 | 597.0 | 611.8 | 657.2 | |
| Other Current Assets | 462.3 | 461.6 | 410.1 | 439.0 | 509.3 | 460.3 | 437.1 | 334.8 | 420.4 | 379.9 | |
| Total Current Assets | 3,755.9 | 3,350.4 | 4,127.8 | 4,629.0 | 4,390.4 | 3,681.7 | 3,539.9 | 3,263.9 | 3,245.8 | 3,009.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 242.4 | 227.0 | 235.0 | 301.4 | 343.4 | 257.1 | 270.9 | 200.4 | 170.1 | 107.5 | 85.6 | 58.4 | 14.2 | 7.3 | 1.6 | 0.7 | |
| Goodwill | 1,735.9 | 1,716.3 | 1,753.1 | 1,692.7 | 1,827.6 | 958.3 | 920.0 | 927.6 | 947.5 | 893.8 | 657.1 | 702.7 | 450.5 | 442.6 | 38.2 | 38.2 | |
| Intangible Assets | 5,079.5 | 4,755.7 | 5,418.0 | 5,794.4 | 7,152.3 | 2,195.1 | 2,441.0 | 2,731.3 | 2,979.1 | 3,012.0 | 1,185.6 | 1,437.4 | 812.4 | 870.0 | 14.6 | 22.0 | |
| Long-Term Investments | 5.1 | 4.3 | 4.7 | 0.0 | 12.0 | 5.2 | 7.4 | 9.6 | 7.7 | 9.7 | 23.3 | 33.2 | 14.6 | 16.6 | 0.0 | 0.0 | |
| Other Long-Term Assets | 257.8 | 119.6 | 69.2 | 64.4 | 40.8 | 25.7 | 47.9 | 42.7 | 16.4 | 14.1 | 27.5 | 15.9 | 7.3 | 3.7 | 0.1 | 0.3 | |
| Total Long-Term Assets | 7,865.9 | 7,383.2 | 7,957.9 | 8,229.1 | 9,687.3 | 3,696.3 | 3,908.6 | 3,969.5 | 4,155.4 | 4,052.2 | 2,102.0 | 2,323.1 | 1,373.6 | 1,414.9 | 54.4 | 61.3 | |
| Total Assets | 11,361.9 | 12,012.3 | 11,393.4 | 10,835.3 | 12,298.6 | 6,535.9 | 5,538.9 | 5,203.5 | 5,123.7 | 4,800.2 | 3,359.7 | 3,339.0 | 2,238.2 | 1,966.5 | 253.6 | 135.7 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 250.1 | 248.1 | 228.1 | 227.0 | 253.6 | 242.4 | 227.9 | 235.0 | 287.5 | 298.3 | |
| Goodwill | 1,827.5 | 1,844.0 | 1,760.0 | 1,716.3 | 1,804.6 | 1,735.9 | 1,739.5 | 1,753.1 | 1,705.3 | 1,742.7 | |
| Intangible Assets | 4,565.7 | 4,769.0 | 4,718.2 | 4,755.7 | 5,144.2 | 5,079.5 | 5,235.5 | 5,418.0 | 5,417.9 | 5,705.8 | |
| Long-Term Investments | 4.3 | 4.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.7 | 7.2 | 7.9 | |
| Other Long-Term Assets | 106.8 | 125.5 | 125.5 | 124.0 | 79.6 | 77.2 | 76.6 | 240.7 | 76.1 | 66.0 | |
| Total Long-Term Assets | 7,600.6 | 7,593.7 | 7,406.9 | 7,383.2 | 7,865.3 | 7,680.2 | 7,787.2 | 8,129.4 | 7,958.3 | 8,250.7 | |
| Total Assets | 11,356.5 | 10,944.1 | 11,534.7 | 12,012.3 | 12,255.7 | 11,361.9 | 11,327.1 | 11,393.4 | 11,204.1 | 11,260.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 97.1 | 77.9 | 102.8 | 90.8 | 100.3 | 26.9 | 47.5 | 40.6 | 24.4 | 22.4 | 21.8 | 25.1 | 21.0 | 15.9 | 5.1 | 3.0 | |
| Short-Term Debt | 622.9 | 45.8 | 624.4 | 31.0 | 31.0 | 246.3 | 33.4 | 33.4 | 40.6 | 36.1 | 37.6 | 9.4 | 5.6 | 29.7 | 39.3 | 23.4 | |
| Other Current Liabilities | 783.8 | 896.2 | 774.5 | 811.0 | 675.9 | 377.9 | 278.8 | 266.1 | 220.4 | 197.8 | 165.9 | 181.1 | 176.3 | 144.8 | 7.3 | 32.2 | |
| Current Liabilities | 1,556.0 | 1,038.6 | 1,536.7 | 933.2 | 809.3 | 653.7 | 364.5 | 345.5 | 293.9 | 257.4 | 226.6 | 216.8 | 204.0 | 191.5 | 52.9 | 59.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 152.2 | 89.4 | 95.9 | 77.9 | 85.4 | 97.1 | 81.0 | 102.8 | 109.9 | 98.4 | |
| Short-Term Debt | 1,043.1 | 1,042.4 | 44.4 | 45.8 | 50.1 | 622.9 | 623.7 | 624.4 | 621.2 | 48.0 | |
| Other Current Liabilities | 1,078.8 | 860.9 | 1,050.5 | 896.2 | 839.5 | 783.8 | 808.2 | 739.4 | 753.2 | 731.3 | |
| Current Liabilities | 2,274.1 | 2,071.2 | 1,222.6 | 1,038.6 | 1,030.0 | 1,556.0 | 1,562.2 | 1,536.7 | 1,573.3 | 945.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 5,101.0 | 6,116.6 | 5,167.2 | 5,765.2 | 6,106.1 | 1,988.6 | 1,725.1 | 1,563.0 | 1,540.4 | 1,993.5 | 1,166.9 | 1,333.0 | 544.4 | 427.1 | 0.0 | 24.6 | |
| Capital Leases | 67.6 | 53.7 | 78.7 | 71.8 | 87.2 | 140.0 | 151.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 775.2 | 676.7 | 847.7 | 944.3 | 1,300.5 | 130.4 | 224.1 | 309.1 | 383.5 | 556.7 | 294.5 | 375.1 | 168.5 | 178.4 | 0.0 | 0.0 | |
| Total Liabilities | 7,599.3 | 7,918.5 | 7,656.4 | 7,749.5 | 8,333.4 | 2,876.2 | 2,427.9 | 2,446.1 | 2,410.6 | 2,922.9 | 1,761.0 | 1,967.7 | 942.7 | 845.2 | 60.8 | 105.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 4,385.4 | 4,390.7 | 5,375.3 | 6,116.6 | 6,151.9 | 5,168.6 | 5,161.3 | 5,167.2 | 5,172.6 | 5,752.2 | |
| Capital Leases | 0.0 | 55.1 | 52.2 | 53.7 | 90.2 | 67.6 | 56.2 | 64.3 | 78.6 | 82.5 | |
| Def. Tax Liability | 629.0 | 682.1 | 670.8 | 676.7 | 791.8 | 775.2 | 809.7 | 847.7 | 841.2 | 910.7 | |
| Total Liabilities | 7,397.5 | 7,237.8 | 7,359.8 | 7,918.5 | 8,084.6 | 7,599.3 | 7,630.6 | 7,656.4 | 7,714.7 | 7,734.9 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Retained Earnings | 871.2 | 1,127.3 | 878.7 | 733.6 | 830.2 | 1,159.9 | 1,067.8 | 841.1 | 918.0 | 528.9 | 302.7 | 34.7 | 18.5 | -61.3 | -349.9 | -474.9 | |
| Comprehensive Income | -887.8 | -947.7 | -842.1 | -1,125.5 | -400.4 | -134.4 | -223.4 | -197.8 | -140.9 | -317.3 | -267.5 | -122.1 | 56.2 | 31.0 | 0.0 | -6.2 | |
| Total Common Equity | 3,762.6 | 4,093.8 | 3,737.0 | 3,085.7 | 3,965.2 | 3,659.7 | 3,111.0 | 2,757.4 | 2,713.1 | 1,877.3 | 1,598.6 | 1,371.1 | 1,295.5 | 1,121.3 | 192.8 | 30.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | 442.7 | 191.3 | 1,034.8 | 1,127.3 | 936.2 | 871.2 | 864.0 | 878.7 | 884.3 | 811.8 | |
| Comprehensive Income | -569.4 | -485.8 | -785.6 | -947.7 | -603.4 | -888.2 | -882.4 | -841.7 | -1,035.4 | -866.8 | |
| Total Common Equity | 3,959.0 | 3,706.4 | 4,174.9 | 4,093.8 | 4,171.1 | 3,762.6 | 3,696.5 | 3,737.0 | 3,489.4 | 3,525.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 5,791.5 | 6,162.4 | 5,791.6 | 5,796.2 | 6,137.1 | 2,234.9 | 1,758.5 | 1,596.4 | 1,581.0 | 2,029.6 | 1,204.5 | 1,342.4 | 550.0 | 456.8 | 0.0 | 48.0 | |
| Book Value | 3,762.6 | 4,093.8 | 3,737.0 | 3,085.7 | 3,965.2 | 3,659.7 | 3,111.0 | 2,757.4 | 2,713.1 | 1,877.3 | 1,598.6 | 1,371.2 | 1,295.5 | 1,121.3 | 192.8 | 30.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 3,959.0 | 3,706.4 | 4,174.9 | 4,093.8 | 4,171.1 | 3,762.6 | 3,696.5 | 3,737.0 | 3,489.4 | 3,525.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 394.9 | -356.1 | 560.1 | 414.8 | -224.1 | -329.7 | 238.6 | 523.4 | 447.1 | 487.8 | 396.8 | 329.5 | 57.3 | 216.3 | 288.6 | 125.0 | 32.8 | |
| Depreciation & Amortization | 648.2 | 696.3 | 660.1 | 638.7 | 629.5 | 552.5 | 278.3 | 370.2 | 216.7 | 165.2 | 113.8 | 108.1 | 133.7 | 82.1 | 74.2 | 7.8 | 8.7 | |
| Stock-Based Compensation | 227.2 | 291.1 | 248.0 | 226.8 | 222.0 | 189.0 | 121.0 | 110.6 | 102.4 | 106.9 | 98.8 | 91.6 | 69.6 | 44.6 | 23.0 | 20.7 | 8.2 | |
| Change Working Capital | -176.0 | 18.9 | -76.7 | -204.4 | 9.9 | -48.0 | -85.4 | -150.1 | 23.3 | 26.8 | -22.7 | -6.1 | -51.4 | -81.0 | -5.2 | -3.6 | -5.8 | |
| Change In Accounts Receivable | -94.0 | -106.3 | -21.1 | 0.0 | -90.1 | -92.7 | -38.6 | -92.3 | -40.1 | 12.3 | -25.6 | -24.8 | -55.0 | -48.8 | -4.7 | -12.3 | -9.8 | |
| Change In Accounts Payable | -2.0 | 39.9 | -20.1 | 9.6 | -11.2 | 57.0 | -18.9 | 4.8 | 17.0 | 0.2 | 0.4 | -2.3 | -38.0 | 5.1 | -7.3 | 2.1 | 0.9 | |
| Change In Inventories | -23.9 | -86.0 | -45.5 | 0.0 | -49.6 | -48.9 | -30.5 | -32.8 | -18.5 | -8.7 | -17.0 | 6.3 | -7.6 | -8.5 | 1.7 | 1.3 | -1.6 | |
| Other Non-cash Items | 1,027.6 | 1,150.6 | 212.7 | 276.3 | 926.9 | 345.4 | 484.2 | 159.0 | 98.2 | 132.0 | 45.0 | 70.1 | 240.0 | 31.7 | -17.1 | 125.4 | 2.4 | |
| Cash from Operations | 1,073.1 | 0.0 | 0.0 | 1,092.0 | 1,272.0 | 778.5 | 899.6 | 776.4 | 798.9 | 693.1 | 590.5 | 531.9 | 405.8 | 283.6 | 249.8 | 151.6 | 58.9 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -903.6 | 251.4 | -718.5 | -92.5 | 191.1 | 215.1 | 168.6 | -14.6 | 94.2 | 146.8 | |
| Depreciation & Amortization | 503.8 | 178.2 | 174.0 | 164.9 | 168.4 | 165.2 | 163.0 | 163.4 | 159.2 | 162.6 | |
| Stock-Based Compensation | 199.8 | 88.1 | 64.5 | 67.7 | 0.0 | 59.8 | 0.0 | 0.0 | 52.9 | 56.1 | |
| Change Working Capital | -72.7 | 130.9 | -327.1 | 287.9 | -79.9 | -26.4 | -26.8 | 56.4 | -181.0 | -24.5 | |
| Change In Accounts Receivable | -65.8 | -51.0 | -55.5 | 66.0 | 0.9 | -22.3 | 8.7 | -8.4 | -75.5 | -18.9 | |
| Change In Accounts Payable | -29.0 | 62.4 | -12.7 | 19.1 | -3.1 | -12.8 | 15.4 | -19.6 | -8.1 | 10.2 | |
| Change In Inventories | 7.7 | -31.9 | -26.2 | -35.6 | -18.7 | -9.3 | -4.7 | -12.8 | -1.4 | -4.9 | |
| Other Non-cash Items | 789.3 | 97.4 | 962.4 | 45.7 | 121.3 | 49.5 | 101.7 | 128.4 | 78.0 | 45.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 167.3 | 307.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -28.4 | -58.8 | -38.1 | -24.0 | -498.2 | -45.5 | -379.3 | -182.3 | -131.5 | -114.0 | -181.6 | -36.0 | -239.0 | -11.3 | -22.5 | -5.8 | -4.7 | |
| Acquisitions | 0.0 | -858.1 | 0.0 | 0.0 | 53.0 | -6,234.8 | -364.3 | -142.2 | 111.1 | 85.0 | -1,502.4 | 33.7 | -828.7 | 0.0 | -448.6 | -4.5 | 0.0 | |
| Investments | -1,015.1 | 0.0 | -1,305.1 | -390.1 | -61.0 | -26.8 | -2,397.7 | -917.1 | -1,165.9 | -385.0 | -65.3 | 0.0 | 0.0 | 0.0 | -37.4 | -79.9 | 0.0 | |
| Sales of Investment | 470.0 | 1,360.0 | 845.0 | 270.0 | 60.0 | 1,095.0 | 1,755.0 | 985.0 | 855.0 | 230.0 | 173.8 | 0.0 | 0.0 | 0.0 | 113.2 | 4.0 | 2.6 | |
| Other Investing Activities | -258.0 | 0.0 | 0.0 | -19.0 | 0.0 | 0.0 | 378.5 | 101.3 | -63.2 | -85.0 | -173.8 | 0.0 | 0.0 | 0.0 | 0.0 | 4.9 | 0.0 | |
| Cash from Investing | -601.5 | 0.0 | 0.0 | -163.1 | -446.2 | -5,212.1 | -1,007.7 | -155.3 | -394.5 | -269.0 | -1,749.3 | -2.3 | -1,067.6 | -11.3 | -395.3 | -81.2 | -2.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -40.7 | -45.2 | -13.0 | -13.9 | -13.3 | -10.8 | -7.1 | -6.9 | -10.1 | -4.3 | |
| Acquisitions | -858.1 | 0.0 | -858.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | -20.0 | |
| Investments | -440.1 | -640.1 | 440.1 | -440.1 | -470.0 | -130.1 | -330.0 | -375.0 | -120.1 | -190.0 | |
| Sales of Investment | 1,090.0 | 400.0 | 470.0 | 310.0 | 290.0 | 355.0 | 80.0 | 120.0 | 250.0 | 20.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -18.0 | 20.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 101.8 | -174.3 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -31.0 | 0.0 | 0.0 | -31.0 | -582.0 | -1,320.6 | -889.6 | -33.4 | -25.7 | -886.1 | -178.3 | -1,065.8 | -309.5 | -465.9 | -11.9 | -49.5 | -136.3 | |
| Debt Issued | 22.4 | 6,162.4 | 370.7 | 26.4 | 241.1 | 5,222.9 | 1,366.0 | 195.5 | 41.1 | 437.5 | 1,003.4 | 927.8 | 1,102.0 | 559.1 | 468.6 | 1.5 | 184.4 | |
| Issuance of Common Stock | 25.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 56.8 | |
| Repurchase of Common Stock | -384.9 | -125.0 | -311.4 | -269.8 | -0.1 | 0.0 | -146.5 | -301.5 | -523.7 | -98.8 | -278.3 | -61.6 | -42.2 | -136.5 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | -112.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -50.1 | 0.0 | 0.0 | -4.5 | 52.6 | 5,291.1 | 1,564.2 | 41.1 | 70.3 | 575.8 | 997.6 | 913.0 | 1,064.6 | 578.4 | 460.4 | 16.4 | 52.0 | |
| Cash from Financing | -396.4 | 0.0 | 0.0 | -305.3 | -529.5 | 3,970.5 | 528.1 | -293.7 | -479.1 | -409.1 | 541.0 | -214.3 | 712.9 | -24.0 | 448.5 | -33.1 | -27.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.8 | -7.8 | |
| Debt Issued | 5,428.5 | -4.6 | 13.4 | -742.7 | -39.7 | 410.5 | 6.5 | -11.7 | 10.5 | 1.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | -125.0 | 0.0 | 0.0 | -150.0 | -161.4 | 0.0 | -99.8 | -74.4 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -112.3 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.2 | 3.6 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -100.3 | -78.5 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 323.5 | -1,021.0 | 906.6 | 624.8 | 290.0 | -466.3 | 420.4 | 327.7 | -76.4 | 20.1 | -622.8 | 304.7 | 47.5 | 249.3 | 305.1 | 37.3 | 29.2 | |
| Closing Cash Balance | 1,295.8 | 1,391.9 | 2,412.9 | 1,506.3 | 881.5 | 591.4 | 1,057.8 | 637.3 | 309.6 | 386.0 | 366.0 | 988.8 | 684.0 | 636.5 | 387.2 | 82.1 | 44.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 75.8 | 46.2 | -672.1 | -550.9 | 234.7 | 862.3 | 62.4 | 27.1 | 180.6 | 53.4 | |
| Closing Cash Balance | 1,311.9 | 1,236.1 | 1,189.9 | 1,861.9 | 2,202.9 | 2,218.1 | 1,295.8 | 1,233.4 | 1,206.3 | 1,335.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1,044.7 | 1,297.0 | 1,347.8 | 1,068.0 | 773.8 | 733.0 | 520.4 | 594.1 | 667.4 | 579.1 | 409.0 | 496.0 | 166.8 | 272.3 | 227.3 | 145.8 | 54.1 | |
| Real Free Cash Flow | 817.6 | 1,005.9 | 1,099.8 | 841.2 | 551.8 | 544.0 | 399.4 | 483.5 | 565.0 | 472.2 | 310.2 | 404.4 | 97.2 | 227.8 | 204.3 | 125.1 | 45.9 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 296.8 | 459.4 | 100.9 | 390.9 | 385.3 | 388.0 | 324.3 | 260.3 | 157.2 | 302.9 | |
| Real Free Cash Flow | 97.0 | 371.3 | 36.4 | 323.3 | 385.3 | 328.2 | 324.3 | 260.3 | 104.3 | 246.8 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -30.9 | 15.6 | -1.4 |
| P/S | 2.6 | 5.2 | 9.4 |
| P/B | 2.8 | -8.9 | 5.2 |
| P/FCF | 13.3 | 27.5 | -1.5 |
| Market cap | $8.1 | $7.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 47.8 % | 37.3 % | 0 % |
| Debt to Income | -1524.2 % | -338.2 % | 0 % |
| Debt to Free cash flow | 655.7 % | 53 % | 0 % |
| Interest expense percentage | 86.9 % | 29.8 % | 44.7 % |
| Current ratio | 1.7 | 3.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -9 % | 0.5 % | 0 % |
| ROA | -3.1 % | 8.4 % | 0 % |
| CapEx to Revenue | 2.1 % | 6.6 % | 0 % |
| RaD to Revenue | 0 % | 12.3 % | 0 % |
| ROEM | 1,524,137.9 | 864973.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 85.4 % | 89.9 % | 68.7 % |
| Operating margin | -11.9 % | 25.5 % | 35.5 % |
| Net margin | -8.9 % | 17.3 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.1 % | 0 % |
| Dividend payout percentage | 0 % | 4.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 61.6 mil | 59.4 mil |
| Employee count | 2.8 tis | 1.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
